Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Sai Life Sciences IPO is a book built issue of Rs 3,042.62 crores. The issue is a combination of fresh issue of 1.73 crore shares aggregating to Rs 950.00 crores and offer for sale of 3.81 crore shares aggregating to Rs 2,092.62 crores.
Sai Life Sciences IPO bidding opened for subscription on December 11, 2024 and will close on December 13, 2024. The allotment for the Sai Life Sciences IPO is expected to be finalized on Monday, December 16, 2024. Sai Life Sciences IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, December 18, 2024.
Sai Life Sciences IPO price band is set at ₹522 to ₹549 per share. The minimum lot size for an application is 27 Shares. The minimum amount of investment required by retail investors is ₹14,823. The minimum lot size investment for sNII is 14 lots (378 shares), amounting to ₹207,522, and for bNII, it is 68 lots (1,836 shares), amounting to ₹1,007,964.
Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd and Iifl Securities Ltd are the book running lead managers of the Sai Life Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Sai Life Sciences IPO RHP for detailed information.
| IPO Date | December 11, 2024 to December 13, 2024 |
| Listing Date | [.] |
| Face Value | ₹1 per share |
| Price Band | ₹522 to ₹549 per share |
| Lot Size | 27 Shares |
| Total Issue Size | 55,421,123 shares (aggregating up to ₹3,042.62 Cr) |
| Fresh Issue | 17,304,189 shares (aggregating up to ₹950.00 Cr) |
| Offer for Sale | 38,116,934 shares of ₹1 (aggregating up to ₹2,092.62 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 190,685,340 |
| Share holding post issue | 207,989,529 |
Sai Life Sciences IPO offers 5,54,21,121 shares. 1,10,84,225 (20%) to QIB, 83,13,168 (15%) to NII, 1,93,97,392 (35%) to RII and 1,66,26,336 (30%) to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 1,66,26,336 (30%) | NA |
| QIB Shares Offered | 1,10,84,225 (20%) | NA |
| NII (HNI) Shares Offered | 83,13,168 (15%) | |
| bNII > ₹10L | 55,42,113 (10%) | 14,661 |
| sNII < ₹10L | 27,71,056 (5%) | 7,330 |
| Retail Shares Offered | 1,93,97,392 (35%) | 7,18,421 |
| Total Shares Offered | 5,54,21,121 (100%) |
Sai Life Sciences IPO raises Rs 912.79 crore from anchor investors. Sai Life Sciences IPO Anchor bid date is December 10, 2024. Sai Life Sciences IPO Anchor Investors list
| Bid Date | December 10, 2024 |
| Shares Offered | 16,626,336 |
| Anchor Portion Size (In Cr.) | 912.79 |
| Anchor lock-in period end date for 50% shares (30 Days) | January 15, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | March 16, 2025 |
Sai Life Sciences IPO opens on December 11, 2024, and closes on December 13, 2024.
| IPO Open Date | Wednesday, December 11, 2024 |
| IPO Close Date | Friday, December 13, 2024 |
| Basis of Allotment | Monday, December 16, 2024 |
| Initiation of Refunds | Tuesday, December 17, 2024 |
| Credit of Shares to Demat | Tuesday, December 17, 2024 |
| Listing Date | Wednesday, December 18, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 13, 2024 |
Investors can bid for a minimum of 27 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹192,699 |
| S-HNI (Min) | 14 | 378 | ₹207,522 |
| S-HNI (Max) | 67 | 1,809 | ₹993,141 |
| B-HNI (Min) | 68 | 1,836 | ₹1,007,964 |
| Lot Size Calculator | |||
The promoters of the company are Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytrey, Sai Quest Syn Private Limited, Sunflower Partners, Lily Partners, Marigold Partners and Tulip Partners.
| Share Holding Pre Issue | 40.48% |
| Share Holding Post Issue | 35.1% |
Incorporated in January 1999, Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.
In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.
The company's business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.
The company has the following service offerings.
As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.
As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.
Competitive Strength:
Sai Life Sciences Limited's revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 | ||||||||||||||||||||||||||||||||||||
| Revenue | 693.35 | 1,494.27 | 1,245.11 | 897.74 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 1,044.75 | 974.34 | 887.29 | 877.76 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 1,025.44 | 953.99 | 867.43 | 859.17 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 764.49 | 710.16 | 699.23 | 751.32 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
The market capitalization of Sai Life Sciences IPO is Rs 11418.63 Cr.
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| P/BV | 10.18 |
| PAT Margin (%) | 5.65 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.34 | 2.69 |
| P/E (x) | 126.42 | 203.82 |
[Dilip Davda] The company is innovation focused CRDMO, NCE, CRO, and CMC entity, and a global player for healthcare related products development serving over 25 world’s leading pharma companies. It marked steady growth in its top lines, but the sudden boost in bottom lines for FY24 raises eyebrows. Based on FY25 annualized earnings, the issue appears aggressively priced. Well-informed/cash surplus/risk seekers may park moderate funds for long term. Read detail review...
Sai Life Sciences Limited
Plot No. DS-7, IKP Knowledge Park
Turkapally Village, Shameerpet Mandal,
Malkajgiri District, Hyderabad-500078
Phone: +9140 6815 6000
Email: investors@sailife.com
Website: https://www.sailife.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sailifesciences.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Sai Life Sciences IPO is a main-board IPO of 55,421,123 equity shares of the face value of ₹1 aggregating up to ₹3,042.62 Crores. The issue is priced at ₹522 to ₹549 per share. The minimum order quantity is 27 Shares.
The IPO opens on December 11, 2024, and closes on December 13, 2024.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Sai Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Sai Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sai Life Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sai Life Sciences IPO opens on December 11, 2024 and closes on December 13, 2024.
Sai Life Sciences IPO lot size is 27 Shares, and the minimum amount required is ₹14,823.
You can apply in Sai Life Sciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Sai Life Sciences IPO will be done on Monday, December 16, 2024, and the allotted shares will be credited to your demat account by Tuesday, December 17, 2024. Check the Sai Life Sciences IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
